Plasmapheresis (PP) is a method of extracorporeal haemocorrection (EHC), based upon replacement of plasma of a patient with blood components / blood preparations, or blood substitutes.
Currently, Therapeutic Plasmapheresis is the most widely used EHC-procedure for treatment of internal diseases (more than 100 various diseases and syndromes).
The method lies in removal of the liquid blood component, plasma, along with toxic substances. At that, all the blood cell elements “return” to the patient.
Plasma components recover in the human body much faster than formed elements of blood. Therefore, patients can easily tolerate this.
In the course of PP, blood cells separate from the plasma. Plasma is removed along with toxins and replaced with various individualized solutions. No foreign blood components are at that used.
THERAPUTIC PLASMEPHERESIS IS AIMED AT AS FOLLOWS:
- 11quick removal of toxic substances from human blood;
- 22quick decrease in contents of pathological factors or cells in blood;
- 3U/S follow-up investigation (where it is required to carry out several repeated investigations in a given time): to obtain consistent results, one has to use one and the same apparatus.
THERAPUTIC PLASMEPHERESIS: PROCEDURE IN START-UP PREPARATION STAGE
The “Edelweiss” health-care center uses high-end medical equipment and high-quality consumables only.
Course of the procedure
In the course of the procedure, blood is drawn from a vein using a needle, connected to a package of single-use systems which, in turn, are connected to an apparatus. Upon the procedure, plasma removed and the systems used are disposed of.
Procedure duration: 1 – 2 hours.
On the procedure day do not visit swimming pools, saunas; do not take part in sports activities and limit consumption of salted food.
EFFECTIVE, SAFE AND FAST
PP counter-indications are as follows.
An absolute contraindication is excessive bleeding which is beyond control. The following counter-indications are considered to be relative ones, as specified below:
- Heart rhythm disorder or blood-clotting disorder;
- Peptic ulcer;
- Insufficient quantity of proteins in plasma;
- Emerging infectious diseases;
- Underdeveloped venous network;
- Menstrual bleeding.